Effect of Peng Block Application on Inflammation and Mortality in Hip Fractures

Launched by ANKARA CITY HOSPITAL BILKENT · Jan 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a specific anesthesia technique called the PENG block on inflammation and the risk of death in older patients (65 years and older) who are having surgery for hip fractures. Researchers want to see if this method can help reduce inflammation in the body and improve recovery by potentially lowering the chances of complications after surgery, as well as reducing the length of time patients need to stay in the hospital.

To be eligible for the study, participants should be aged 65 or older and scheduled for hip fracture surgery. They should have a general health score (known as ASA) of 1 to 3, which means they are in relatively good health or have mild to moderate health issues. However, patients who are very ill, have obesity, or have certain other medical conditions may not be able to take part in the study. Those who join can expect close monitoring during the trial, and their experience will help researchers understand how this anesthesia technique may benefit patients undergoing hip surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ASA 1-2-3 score
• • Hip Fracture Surgery
• Exclusion Criteria:
• • Refusal to participate in the study
• • ASA score of 4 and above
• • Obesity (BMI \>40)
• • Failure of spinal block
• • Switching to general anesthesia
• • Patients undergoing revision surgery
• • Patients with multitrauma
• • Patients with old fractures (\>3 weeks)
• • Patients receiving preoperative and intraoperative sedation
• • Patients with active malignancy receiving RT, KT
• • Patients with active infection, patients receiving antibiotic treatment
• • Patients with contraindications for regional anesthesia techniques
• • Patients receiving chronic treatment with steroids or immunosuppressants
• • Patients using anti-inflammatory drugs